Annual Current Liabilities
$8.65 M
+$7.29 M+535.71%
31 December 2023
Summary:
AIM ImmunoTech annual total current liabilities is currently $8.65 million, with the most recent change of +$7.29 million (+535.71%) on 31 December 2023. During the last 3 years, it has risen by +$7.55 million (+685.12%). AIM annual current liabilities is now -31.60% below its all-time high of $12.65 million, reached on 31 December 2012.AIM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$10.10 M
+$1.26 M+14.23%
30 September 2024
Summary:
AIM ImmunoTech quarterly total current liabilities is currently $10.10 million, with the most recent change of +$1.26 million (+14.23%) on 30 September 2024. Over the past year, it has increased by +$5.38 million (+114.16%). AIM quarterly current liabilities is now -20.15% below its all-time high of $12.65 million, reached on 31 December 2012.AIM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +535.7% | +114.2% |
3 y3 years | +685.1% | +1216.8% |
5 y5 years | +63.5% | +141.0% |
AIM Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +1185.6% | at high | +1400.7% |
5 y | 5 years | at high | +1185.6% | at high | +1400.7% |
alltime | all time | -31.6% | +1185.6% | -20.1% | +1400.7% |
AIM ImmunoTech Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $10.10 M(+14.2%) |
June 2024 | - | $8.84 M(-10.5%) |
Mar 2024 | - | $9.88 M(+14.1%) |
Dec 2023 | $8.65 M(+535.7%) | $8.65 M(+83.5%) |
Sept 2023 | - | $4.72 M(+63.5%) |
June 2023 | - | $2.88 M(+57.0%) |
Mar 2023 | - | $1.84 M(+35.0%) |
Dec 2022 | $1.36 M(+102.2%) | $1.36 M(-53.0%) |
Sept 2022 | - | $2.90 M(+111.6%) |
June 2022 | - | $1.37 M(+78.6%) |
Mar 2022 | - | $766.00 K(+13.8%) |
Dec 2021 | $673.00 K(-38.9%) | $673.00 K(-12.3%) |
Sept 2021 | - | $767.00 K(-12.4%) |
June 2021 | - | $876.00 K(-9.7%) |
Mar 2021 | - | $970.00 K(-12.0%) |
Dec 2020 | $1.10 M(-2.2%) | $1.10 M(+38.6%) |
Sept 2020 | - | $795.00 K(-4.6%) |
June 2020 | - | $833.00 K(+18.5%) |
Mar 2020 | - | $703.00 K(-37.6%) |
Dec 2019 | $1.13 M(-78.7%) | $1.13 M(-73.1%) |
Sept 2019 | - | $4.19 M(+139.9%) |
June 2019 | - | $1.75 M(-16.3%) |
Mar 2019 | - | $2.09 M(-60.6%) |
Dec 2018 | $5.29 M(+95.5%) | $5.29 M(+6.7%) |
Sept 2018 | - | $4.96 M(+138.9%) |
June 2018 | - | $2.08 M(-21.6%) |
Mar 2018 | - | $2.65 M(-2.1%) |
Dec 2017 | $2.71 M(+11.2%) | $2.71 M(+23.0%) |
Sept 2017 | - | $2.20 M(-19.8%) |
June 2017 | - | $2.74 M(+4.1%) |
Mar 2017 | - | $2.64 M(+8.3%) |
Dec 2016 | $2.44 M(+0.1%) | $2.44 M(+0.2%) |
Sept 2016 | - | $2.43 M(-45.1%) |
June 2016 | - | $4.43 M(+43.2%) |
Mar 2016 | - | $3.09 M(+27.1%) |
Dec 2015 | $2.43 M(-45.2%) | $2.43 M(-26.9%) |
Sept 2015 | - | $3.33 M(+7.3%) |
June 2015 | - | $3.10 M(-18.8%) |
Mar 2015 | - | $3.82 M(-13.9%) |
Dec 2014 | $4.44 M(+75.2%) | $4.44 M(+4.2%) |
Sept 2014 | - | $4.26 M(+2.3%) |
June 2014 | - | $4.16 M(+39.3%) |
Mar 2014 | - | $2.99 M(+18.0%) |
Dec 2013 | $2.53 M(-80.0%) | $2.53 M(-76.2%) |
Sept 2013 | - | $10.63 M(+7.8%) |
June 2013 | - | $9.86 M(-1.7%) |
Mar 2013 | - | $10.03 M(-20.7%) |
Dec 2012 | $12.65 M(+149.5%) | $12.65 M(+29.2%) |
Sept 2012 | - | $9.79 M(+33.1%) |
June 2012 | - | $7.36 M(+23.0%) |
Mar 2012 | - | $5.98 M(+18.0%) |
Dec 2011 | $5.07 M(+79.0%) | $5.07 M(+40.7%) |
Sept 2011 | - | $3.60 M(+84.9%) |
June 2011 | - | $1.95 M(-31.2%) |
Mar 2011 | - | $2.83 M(0.0%) |
Dec 2010 | $2.83 M | $2.83 M(+19.9%) |
Sept 2010 | - | $2.36 M(+25.7%) |
June 2010 | - | $1.88 M(-23.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $2.46 M(-6.0%) |
Dec 2009 | $2.62 M(+56.9%) | $2.62 M(+88.8%) |
Sept 2009 | - | $1.39 M(-45.4%) |
June 2009 | - | $2.54 M(+3.6%) |
Mar 2009 | - | $2.45 M(+46.8%) |
Dec 2008 | $1.67 M(-23.8%) | $1.67 M(-22.9%) |
Sept 2008 | - | $2.16 M(+11.7%) |
June 2008 | - | $1.94 M(-12.2%) |
Mar 2008 | - | $2.21 M(+0.8%) |
Dec 2007 | $2.19 M(-67.3%) | $2.19 M(-17.9%) |
Sept 2007 | - | $2.66 M(-6.8%) |
June 2007 | - | $2.86 M(-58.7%) |
Mar 2007 | - | $6.91 M(+3.5%) |
Dec 2006 | $6.68 M(+259.9%) | $6.68 M(-7.4%) |
Sept 2006 | - | $7.22 M(+6.6%) |
June 2006 | - | $6.77 M(+187.4%) |
Mar 2006 | - | $2.36 M(+26.9%) |
Dec 2005 | $1.86 M(-47.6%) | $1.86 M(-67.6%) |
Sept 2005 | - | $5.74 M(+1.1%) |
June 2005 | - | $5.67 M(+10.9%) |
Mar 2005 | - | $5.12 M(+44.4%) |
Dec 2004 | $3.54 M(+120.6%) | $3.54 M(-2.6%) |
Sept 2004 | - | $3.64 M(+28.5%) |
June 2004 | - | $2.83 M(-39.5%) |
Mar 2004 | - | $4.68 M(+191.3%) |
Dec 2003 | $1.61 M(+9.8%) | $1.61 M(-22.1%) |
Sept 2003 | - | $2.06 M(+21.1%) |
June 2003 | - | $1.70 M(-39.7%) |
Mar 2003 | - | $2.83 M(+93.0%) |
Dec 2002 | $1.46 M(+15.1%) | $1.46 M(+56.7%) |
Sept 2002 | - | $934.00 K(+14.2%) |
June 2002 | - | $818.00 K(-39.4%) |
Mar 2002 | - | $1.35 M(+6.1%) |
Dec 2001 | $1.27 M(-14.9%) | $1.27 M(+1.8%) |
Sept 2001 | - | $1.25 M(+11.3%) |
June 2001 | - | $1.12 M(-9.4%) |
Mar 2001 | - | $1.24 M(-17.1%) |
Dec 2000 | $1.50 M(-0.3%) | $1.50 M(+65.5%) |
Sept 2000 | - | $903.40 K(-27.4%) |
June 2000 | - | $1.25 M(+5.4%) |
Mar 2000 | - | $1.18 M(-21.2%) |
Dec 1999 | $1.50 M(+36.4%) | $1.50 M(-28.6%) |
Sept 1999 | - | $2.10 M(-4.5%) |
June 1999 | - | $2.20 M(+29.4%) |
Mar 1999 | - | $1.70 M(+54.5%) |
Dec 1998 | $1.10 M(+37.5%) | $1.10 M(+22.2%) |
Sept 1998 | - | $900.00 K(-10.0%) |
June 1998 | - | $1.00 M(+25.0%) |
Mar 1998 | - | $800.00 K(0.0%) |
Dec 1997 | $800.00 K(-27.3%) | $800.00 K(-42.9%) |
Sept 1997 | - | $1.40 M(+40.0%) |
June 1997 | - | $1.00 M(0.0%) |
Mar 1997 | - | $1.00 M(-9.1%) |
Dec 1996 | $1.10 M(-86.7%) | $1.10 M(0.0%) |
Sept 1996 | - | $1.10 M(-21.4%) |
June 1996 | - | $1.40 M(+7.7%) |
Mar 1996 | - | $1.30 M(-84.3%) |
Dec 1995 | $8.30 M | $8.30 M |
FAQ
- What is AIM ImmunoTech annual total current liabilities?
- What is the all time high annual current liabilities for AIM ImmunoTech?
- What is AIM ImmunoTech annual current liabilities year-on-year change?
- What is AIM ImmunoTech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly current liabilities year-on-year change?
What is AIM ImmunoTech annual total current liabilities?
The current annual current liabilities of AIM is $8.65 M
What is the all time high annual current liabilities for AIM ImmunoTech?
AIM ImmunoTech all-time high annual total current liabilities is $12.65 M
What is AIM ImmunoTech annual current liabilities year-on-year change?
Over the past year, AIM annual total current liabilities has changed by +$7.29 M (+535.71%)
What is AIM ImmunoTech quarterly total current liabilities?
The current quarterly current liabilities of AIM is $10.10 M
What is the all time high quarterly current liabilities for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly total current liabilities is $12.65 M
What is AIM ImmunoTech quarterly current liabilities year-on-year change?
Over the past year, AIM quarterly total current liabilities has changed by +$5.38 M (+114.16%)